Hong Kong Science and Technology Parks

Hong Kong Science and Technology Parks

Hong Kong Science and Technology Parks Corporation (HKSTP) was incorporated in 2001 as a statutory body to reposition Hong Kong from a trading port to an innovation-driven economy. Sunny Chai, an industrialist who co-founded electronic components manufacturer Computime, was appointed chairman in 2018. The Corporation reports to the Innovation and Technology Commission, with the Financial Secretary as the sole shareholder — placing public-policy mandate at the core of its governance rather than private wealth management or institutional limited-partner returns. HKSTP deploys capital indirectly through infrastructure and ecosystem services. Its flagship Hong Kong Science Park in Sha Tin houses companies targeting Life Sciences, Artificial Intelligence, Robotics, and Smart City applications. Corporate partners include AstraZeneca, which operates a healthcare innovation platform on-site, and China Resources Holdings, which co-runs the 'Beyond Dreams' talent initiative to place Hong Kong graduates in Mainland tech firms. The Corporation also manages three industrial estates — Tai Po, Tseung Kwan O, and Yuen Long InnoParks — where precision manufacturing and logistics tenants can prototype and scale. Across the border, the Hong Kong Science Park Shenzhen Branch in Futian and the emerging Hong Kong-Shenzhen Innovation and Technology Park at the Lok Ma Chau Loop extend the model into the Greater Bay Area. HKSTP does not operate a traditional fund; it seeds startups through its Corporate Venture Fund and connects them to a network of over 300 angel and venture investors (per South China Morning Post, 2023). In addition to the parks, HKSTP runs InnoCell, a 392-unit smart-living residential building for park talent, and the InnoCentre in Kowloon Tong, a hub for design and fashion-tech startups. The organization has produced at least 36 initial public offerings from its incubation programs, including gene-testing firm Prenetics and AI-powered logistics platform Lalamove. In May 2024, HKSTP launched a HK$1 billion 'Innovation and Technology Venture Fund' co-investment scheme to match private capital for Series B and later-stage park companies (per the firm, May 2024). The Corporation's philanthropic arm, the HKSTP Foundation, runs STEM scholarships and community outreach programs. HKSTP's structural differentiator is its statutory monopoly on science-park development in Hong Kong — it owns the land, the buildings, the programs, and the public mandate. This vertical integration lets it negotiate corporate partnerships and cross-border facility access that a private real estate developer or venture capital firm cannot replicate. The model ties its performance to Hong Kong's re-industrialization policy rather than a closed-end fund's internal rate of return, making its deployment pace and tenant mix a direct read on government innovation strategy.